HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsubota, K. Articles by Takeuchi, T. Search for Related Content PubMed PubMed Citation Articles by Tsubota, K. Articles by Takeuchi, T.

Mikulicz’s Disease and Sjögren’s Syndrome

¹ From the Department of Ophthalmology, Tokyo Dental College, Chiba, Japan; the ² Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan; the ³ Oral Health Science Center, Tokyo Dental College, Chiba, Japan; and the ⁴ 2nd Department of Internal Medicine, Saitama Medical Center, Saitama, Japan.

PURPOSE. To characterize lacrimal gland function and lymphocyte infiltration in patients with Mikulicz’s disease (MD) and Sjögren’s syndrome (SS).

METHODS. Four patients with MD and 5 with SS were recruited, on whom were performed Schirmer test I (Schirmer test without anesthesia), Schirmer test with nasal stimulation, and vital staining of the ocular surface. The lacrimal gland was then biopsied and the tissues stained with CD3, CD4, CD8, B220, APO2.7, Fas, and Fas ligand (Fas-L) antibodies.

RESULTS. Although regular Schirmer test results in the MD group were less than 10 mm, those with nasal stimulation, 38.1 ± 3.4 mm, were significantly greater than the SS group. There were minimal ocular surface changes in MD. Morphologic staining with hematoxylin and eosin was identical in both groups, but the acinar cells were stained with APO2.7 only in the SS group. There was strong Fas and Fas-L staining in SS patients but not in those with MD.

CONCLUSIONS. Lacrimal gland acinar cells in those with MD maintained their function and were not programmed for cell death. The sicca syndrome was not observed in MD patients. Although the pathology is similar for MD and SS, the difference in acinar cell apoptosis and function can explain clinical differences.

This article has been cited by other articles:

				M. L. McDonald, Y. Wang, S. Selvam, T. Nakamura, R. H. Chow, J. E. Schechter, S. C. Yiu, and A. K. Mircheff Cytopathology and Exocrine Dysfunction Induced in Ex Vivo Rabbit Lacrimal Gland Acinar Cell Models by Chronic Exposure to Histamine or Serotonin Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3164 - 3175. [Abstract] [Full Text] [PDF]

				M. Yamamoto, H. Takahashi, K. Hasebe, C. Suzuki, Y. Naishiro, T. Hayashi, H. Yamamoto, T. Ishida, and Y. Shinomura The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castleman's disease Rheumatology, July 1, 2009; 48(7): 860 - 862. [Full Text] [PDF]

				M. Takahira, M. Kawano, Y. Zen, H. Minato, K. Yamada, and K. Sugiyama IgG4-Related Chronic Sclerosing Dacryoadenitis Arch Ophthalmol, November 1, 2007; 125(11): 1575 - 1578. [Full Text] [PDF]

				D. I. Koufakis, C. H. Karabatsas, L. I. Sakkas, A. Alvanou, A. K. Manthos, and D. Z. Chatzoulis Conjunctival Surface Changes in Patients with Sjogren's Syndrome: A Transmission Electron Microscopy Study Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 541 - 544. [Abstract] [Full Text] [PDF]

				M. Yamamoto, S. Harada, M. Ohara, C. Suzuki, Y. Naishiro, H. Yamamoto, H. Takahashi, Y. Shinomura, and K. Imai Beneficial effects of steroid therapy for Mikulicz's disease Rheumatology, October 1, 2005; 44(10): 1322 - 1323. [Full Text] [PDF]

				Y. Kawai, M. Sumi, H. Kitamori, Y. Takagi, and T. Nakamura Diffusion-Weighted MR Microimaging of the Lacrimal Glands in Patients with Sjogren's Syndrome Am. J. Roentgenol., April 1, 2005; 184(4): 1320 - 1325. [Abstract] [Full Text] [PDF]

				M. Yamamoto, S. Harada, M. Ohara, C. Suzuki, Y. Naishiro, H. Yamamoto, H. Takahashi, and K. Imai Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome Rheumatology, February 1, 2005; 44(2): 227 - 234. [Abstract] [Full Text] [PDF]

				K. Tsubota, H. Fujita, K. Tadano, T. Takeuchi, T. Murakami, I. Saito, and Y. Hayashi Improvement of Lacrimal Function by Topical Application of CyA in Murine Models of Sjogren's Syndrome Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 101 - 110. [Abstract] [Full Text]